Discovery and Applied Research for Technological Innovations to Improve Human Health — CFDA 93.286

Health-technology research obligations at $2.80 billion

USAspending.gov records $2,802,273,381.61 in obligations under CFDA 93.286. One thousand nine hundred thirteen awards produce that stock. A simple average is about $1.46 million per award — in the range of multi-year biomedical research awards rather than billion-dollar procurement. That average is a quotient of two packet totals, not a typical device-development budget.

The assistance-listing title is DISCOVERY AND APPLIED RESEARCH FOR TECHNOLOGICAL INNOVATIONS TO IMPROVE HUMAN HEALTH. CFDA 93.286 is the identifier. Other NIH institute listings tagged under different CFDA numbers are not mixed into the $2.80 billion. Combining those codes would invent a combined biomedical-research total this packet does not contain.

353 recipients and a dense award book

Three hundred fifty-three recipients share 1,913 awards, or about 5.4 award records per recipient on average. Splitting $2.80 billion evenly would assign about $7.94 million per recipient. That density is the research-portfolio pattern: several concurrent awards per university, hospital, or lab rather than one large pass-through. The packet does not list the 353. Recipient count is the organizational headcount, not a census of principal investigators, devices, or patients.

Forty-six states in the geographic count show broad but not universal coding in the USAspending state field. Biomedical technology dollars still concentrate where research universities and medical centers sit. Place-of-performance amounts are on the program table.

Award count is not a device or trial count

Among health-research listings, 93.286 is a high-row file: 1,913 awards against 353 recipients. Multi-year awards, supplements, and amendments can inflate award count relative to unique projects. Award count is therefore a weak proxy for “number of health-technology projects.” Recipients (353) tell you how many named organizations sit on the extract; awards (1,913) tell you how many assistance rows were stored.

The packet does not report FDA clearances, imaging units, or publication counts. Citing 1,913 as devices or trials would be a unit error. Keep the units straight: dollars, awards, recipients, states.

Obligations versus research outlays

The $2.80 billion is an obligation total from USAspending.gov. Outlays — cash paid against these research awards — are not in the packet. A laboratory can show a large obligation stock while work follows a multi-year calendar. Deobligations and upward adjustments both move the total. A remaining-balance question is an outlay question this extract does not answer.

Use CFDA 93.286 to size this health-technology research listing in the assistance file. Do not use it as a device-approval dashboard. Those series live elsewhere. This page reports the obligation book tagged 93.286.

What the 93.286 tables omit

The Discovery and Applied Research hub lists award-backed obligations from USAspending.gov. It is not a device registry, not a clinical-trial index, and not a patient-outcome report. Series that never appear as assistance awards will not show up in the $2,802,273,381.61. That omission is definitional rather than a gap in the 1,913 award rows.

Place-of-performance on 46 states is a coding field. Read the program page before treating those cells as equal shares. Recipient dollars, if shown on the hub, are still obligation amounts, not cash already spent on equipment or staff.

Where the 93.286 table lives

The program page overlays these four facts. The all-programs index ranks 93.286 among other assistance listings. Agency pages show awarding-agency rollups that may include this CFDA among other health-research listings. For 93.286 only, start on the program page.

CFDA 93.286’s 1,913 awards spread $2,802,273,381.61 across 353 recipients and 46 states. Quote award count as a record count, recipient count as the organizational headcount, and dollars as obligations from USAspending.gov. About 5.4 award records per recipient is the density story on this listing. Outlays remain a separate column. Source: USAspending.gov assistance awards. Read 93.286 as a dense health-technology research book: 1,913 awards on 353 organizations is the investigator-portfolio pattern, not a handful of formula pass-throughs. The $2.80 billion remains an obligation stock on USAspending.gov.

Questions

How much is obligated under CFDA 93.286?

USAspending.gov records $2,802,273,381.61 in obligations for CFDA 93.286. SpendingVault indexes 1,913 awards, 353 recipients, and 46 states. The figure is an obligation sum from assistance awards, not an outlay and not a device count. CFDA 93.286’s $2.80 billion is the USAspending obligation stock.

How many awards does CFDA 93.286 carry?

The listing shows 1,913 awards against 353 recipients, or about 5.4 award records per recipient. A simple average is about $1.46 million per award. Award count is not a device or trial count. Recipient dollars are on the program page.

How many organizations receive 93.286 awards?

The extract lists 353 recipients. Those are organizational recipients on assistance awards tagged 93.286. Geographic coding covers 46 states. The packet does not name the 353 or publish device or trial data. Recipient count is the organizational headcount.

Is $2.80 billion already spent on this health-technology research?

Not necessarily. Obligations are commitments. Outlays are payments. CFDA 93.286’s indexed total is the obligation stock from USAspending.gov. This page does not report cash drawn, remaining balances, or devices cleared. The $2.80 billion on 1,913 awards is the obligation figure.